News
Vielseitige Anwendungen der universell einsetzbaren Soft-Robotik von Wisson Robotics sind ein Highlight auf der CES 2025
LAS VEGAS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Der Stand von Wisson Robotics auf der CES 2025 hat mit Live-Demos modernster Soft-Robotik und auf der Pliabot®-Technologie basierenden Anwendungen in
Universell einsetzbare Soft-Robotik erregt auf der CES mit vielseitigen Anwendungen Aufmerksamkeit
LAS VEGAS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Robotik ist auch in diesem Jahr wieder ein Highlight auf der CES gewesen. Neben den üblichen humanoiden und Haushalts-Servicerobotern stellte Wisson
Sonova gibt personelle Veränderungen im Verwaltungsrat bekannt
Debüt der fliegenden Soft-Roboter von Wisson Robotics auf der CES 2025: ultimativ sichere, effiziente und vielseitige Präzisionsarbeiten in der Luft
HONGKONG, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Wisson Robotics, ein globaler Pionier auf dem Gebiet der Mehrzweck-Soft-Roboter, wird auf der CES 2025 seine innovativen fliegenden Soft-Roboter zeigen
Johnson & Johnson beantragt bei der Europäischen Arzneimittelagentur die Zulassung für eine neue Indikation von IMBRUVICA® (ibrutinib) bei erwachsenen Patienten mit unbehandeltem Mantelzell-Lymphom (MCL), die für eine autologe Stammzelltransplantatio
Die Phase III-Studie TRIANGLE des europäischen MCL-Netzwerks untersuchte ibrutinib in Kombination mit einer Induktions-Immunochemotherapie mit oder ohne autologe Stammzelltransplantation, gefolgt
EMGA sichert sich 90 Mio. US-Dollar von der EIB für die brasilianische BTG Pactual
LONDON, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Emerging Markets Global Advisory LLP (EMGA) gibt heute bekannt, eine Fremdfinanzierung in Höhe von 90 Millionen US-Dollar für ihren langjährigen
Top 3 Cutting-Edge Micro-Caps Set for 2025 Growth
As 2025 approaches, several promising micro-cap stocks are gaining attention for their potential to disrupt key industries. These companies, though small in market size, are making significant
EQS-News: Gerresheimer: FDA erteilt „Tentative Approval“ für Lasix von SQ Innovation® ONYU*
EQS-News: Evotec closes sale of Just – Evotec Biologics’ Toulouse site to Sandoz
The Healthcare Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar.
Over the last three months, the S&P 500 healthcare sector has risen 13%, compared to the broader S&P 500 index's 7% increase.
However, one stock that hasn't matched its sector's returns is Halozyme
EQS-News: Evotec-partner Bayer starts Phase 2 study for treatment of patients with Alport syndrome
Why Amentum Holdings Stock Rocked the Market Today
Just after market close on Monday, Amentum Holdings (NYSE: AMTM) posted its latest set of quarterly figures. This led to a bull stampede into the stock the following day, with eager investors
EQS-News: Gerresheimer AG: Change in the Supervisory Board
Why Shares in Agios Pharmaceuticals Got Crushed Today
Shares in Agios Pharmaceuticals (NASDAQ: AGIO) crashed by 50% by noontime today. The move comes as the market digests a mixed set of topline results from its Phase 3 trial (RISE UP) of its sickle
EQS-News: Gerresheimer: Science Based Targets Initiative confirms CO2e Reduction Targets
4D Advisors Offloads $7.6 Million in Masimo (MASI) Stock, Selling 45,000 Shares
On Nov. 14, 2025, 4D Advisors, LLC disclosed in a regulatory filing that it sold out its entire position in Masimo (NASDAQ:MASI). The sale was valued at $7.57 million.
According to a filing with the
EQS-News: Evotec receives milestone payment from Bristol Myers Squibb following IND acceptance in strategic protein degradation partnership
SG Capital Dumps Nearly 732,000 Haemonetics Shares Worth $59.1 Million
SG Capital Management LLC reduced its holding in Haemonetics Corporation (NYSE:HAE) by 731,892 shares, a position value decline of $59,133,712, per November 07, 2025, SEC filings.
According to a fil
Why Haemonetics Stock Was on Fire Thursday
Niche healthcare stock Haemonetics (NYSE: HAE) was a winner among the clutch of publicly traded companies reporting quarterly earnings on Thursday. On the back of an estimates-beating second quarter
Brown Capital Sells $35 Million in Glaukos Stock After Sharp Sell-Off
Baltimore-based Brown Capital Management reported a sale of 376,359 Glaukos Corporation shares for an estimated $34.6 million in the third quarter, according to an SEC filing.
Brown Capital
EQS-News: RHÖN-KLINIKUM AG closes third quarter of 2025 with solid results
Renaissance Group Opens New $35M Position in Halozyme Therapeutics (NASDAQ: HALO): Why This Biotech Stock Is Worth a Look
On November 5, 2025, Renaissance Group LLC initiated a new position in Halozyme Therapeutics (NASDAQ:HALO), acquiring 478,735 shares for an estimated $35.11 million, according to a recent SEC
EQS-News: Evotec SE reports 9M 2025 results: Continued strong execution on strategic priorities
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a